|
AKTX
|
Akari Therapeutics Plc
|
US
|
NASDAQ
|
|
ALPN
|
Alpine Immune Sciences, Inc.
|
US
|
NASDAQ
|
|
AMGN
|
Amgen Inc.
|
US
|
NASDAQ
|
|
AMTI
|
Applied Molecular Transport Inc.
|
US
|
NASDAQ
|
|
APLS
|
Apellis Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
ATNF
|
180 Life Sciences Corp.
|
US
|
NASDAQ
|
|
AZN
|
Astrazeneca PLC
|
US
|
NASDAQ
|
|
CANF
|
Can-Fite Biopharma Ltd Sponsored ADR (Israel)
|
US
|
AMEX
|
|
CCXI
|
ChemoCentryx, Inc.
|
US
|
NASDAQ
|
|
CTKB
|
Cytek Biosciences, Inc.
|
US
|
NASDAQ
|
|
CYCC
|
Cyclacel Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
CYCCP
|
Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock
|
US
|
NASDAQ
|
|
DVAX
|
Dynavax Technologies Corporation
|
US
|
NASDAQ
|
|
EVLO
|
Evelo Biosciences, Inc.
|
US
|
NASDAQ
|
|
GLPG
|
Galapagos NV
|
US
|
NASDAQ
|
|
HZNP
|
Horizon Pharma, Inc.
|
US
|
NASDAQ
|
|
IDRA
|
Idera Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
IFRX
|
InflaRx N.V.
|
US
|
NASDAQ
|
|
IPHA
|
Innate Pharma S.A.
|
US
|
NASDAQ
|
|
LIAN
|
LianBio
|
US
|
NASDAQ
|